PURIFICATION OF INTERLEUKIN-2 ANTIBODIES FROM HEALTHY-INDIVIDUALS

被引:20
作者
MONTI, E
POZZI, A
TIBERIO, L
MORELLI, D
CARUSO, A
VILLA, ML
BALSARI, A
机构
[1] UNIV BRESCIA,DEPT BIOMED SCI & BIOTECHNOL,I-25123 BRESCIA,ITALY
[2] UNIV MILAN,SCH MED,CHAIR IMMUNOL,I-20122 MILAN,ITALY
[3] INST MICROBIOL,I-25123 BRESCIA,ITALY
关键词
INTERLEUKIN; 2; NATURAL ANTIBODY; AFFINITY CHROMATOGRAPHY;
D O I
10.1016/0165-2478(93)90098-M
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
By covalent binding of recombinant interleukin-2 (rIL-2) to Sepharose, it was possible to immunopurify specific human anti-IL-2 antibodies from a pool of immunoglobulins obtained from healthy subjects. Since low quantities of the ligand released by the matrix could interfere with the evaluation of the biological activity of anti-IL-2 antibodies, the antibody preparation was subjected to pepsin digestion which is known to destroy the IL-2 molecule. Purified human anti-IL-2 antibodies were found to be mostly IgG1 and able to neutralize IL-2 induced peripheral blood lymphocytes (PBL) proliferation in vitro. The availability of purified anti-IL-2 antibodies, obtained from healthy individuals, able to modulate IL-2 activity, could be important in several therapeutic approaches.
引用
收藏
页码:261 / 266
页数:6
相关论文
共 17 条
[1]   THE DEVELOPMENT OF ANTI-INTERLEUKIN-2 ANTIBODIES IN PATIENTS TREATED WITH RECOMBINANT HUMAN INTERLEUKIN-2 (IL-2) [J].
ALLEGRETTA, M ;
ATKINS, MB ;
DEMPSEY, RA ;
BRADLEY, EC ;
KONRAD, MW ;
CHILDS, A ;
WOLFE, SN ;
MIER, JW .
JOURNAL OF CLINICAL IMMUNOLOGY, 1986, 6 (06) :481-490
[2]  
BALKWILL FR, 1989, IMMUNOL TODAY, V10, P289
[3]   AUTOANTIBODIES TO CYTOKINES - FRIENDS OR FOES [J].
BENDTZEN, K ;
SVENSON, M ;
JONSSON, V ;
HIPPE, E .
IMMUNOLOGY TODAY, 1990, 11 (05) :167-169
[4]  
BOST KL, 1988, IMMUNOLOGY, V65, P611
[5]  
CARUSO A, 1990, J IMMUNOL, V144, P685
[6]  
FOMSGAARD A, 1989, SCAN J IMMUNOL, V4, P489
[7]   IL-2 ANTIBODY-PRODUCTION IN LUPUS MICE [J].
ISHIZAKA, S ;
TSUJII, T .
CELLULAR IMMUNOLOGY, 1989, 118 (01) :100-107
[8]  
MOGENSEN KE, 1981, LANCET, V2, P1227
[9]  
PANEM S, 1982, J IMMUNOL, V129, P1
[10]  
PRUMMER O, 1989, J INTERFERON RES, V9, P67